§ 358.301. Scope.
69 words·~1 min read·
/us/cfr/t21/s§ 358.301·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)An over-the-counter ingrown toenail relief drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each condition in this subpart and each general condition established in § 330.1 of this chapter.
(b)References in this subpart to regulatory sections of the Code of Federal Regulations are to chapter 1 of title 21 unless otherwise noted.